Want to join the conversation?
$LIVN announced long term results from the RESPOND-CRT clinical trial after an 18 month follow-up period. The trial was designed to investigate the clinical efficacy and safety of device-based optimization using $LIVN's proprietary SonR cardiac contractility sensor technology in patients with advanced heart failure.
Wow! $MCD scores again.
$SPY can the rally continue? La Pen almost assured to lose makes me cautious about the results, not a place to panic. If 2400 is reached I'm selling my puts and going for broke. Happy hunting.
Trivago N.V. (TRVG) announced today that it will release its financial results for the first quarter for the period ended March 31, 2017 on Monday, May 15, 2017. On the same day, trivago N.V.`s management will conduct a webcast beginning at 2:00 PM CET / 8:00 AM Eastern Time. These items will be available in the Investor Relations section of the company`s website at http://ir.trivago.com.